The effect of levothyroxine in comparison with placebo on serum osteocalcin levels in patients with subclinical hypothyroidism
CONCLUSION: Levothyroxine had no significant effect on increasing the levels of serum osteocalcin in patients with subclinical hypothyroidism. We have registered the trial in the Iranian registry of clinical trials (IRCT) with the registration code IRCT20171129037677N1.PMID:34036915 | DOI:10.2174/1574886316666210525102230
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Reihaneh Rezaee Masoud Mohebbi Mozhgan Afkhamizadeh Mohammad Ali Yaghoubi Mona Najaf Najafi Mansoureh Hoseinzadeh Amirhossein Sahebkar Source Type: research
More News: Clinical Trials | Drugs & Pharmacology | Eating Disorders & Weight Management | Hormones | Hypothyroidism | Insulin | Iran Health | Levothyroxine | Middle East Health | Obesity | Study | Synthroid | Thyroid